BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14751267)

  • 1. Caspase multiplexing: simultaneous homogeneous time-resolved quenching assay (TruPoint) for caspases 1, 3, and 6.
    Karvinen J; Elomaa A; Mäkinen ML; Hakala H; Mukkala VM; Peuralahti J; Hurskainen P; Hovinen J; Hemmilä I
    Anal Biochem; 2004 Feb; 325(2):317-25. PubMed ID: 14751267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneous time-resolved fluorescence quenching assay (LANCE) for caspase-3.
    Karvinen J; Hurskainen P; Gopalakrishnan S; Burns D; Warrior U; Hemmilä I
    J Biomol Screen; 2002 Jun; 7(3):223-31. PubMed ID: 12097185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of lanthanide(III) chelates to oligopeptides on solid phase.
    Peuralahti J; Hakala H; Mukkala VM; Loman K; Hurskainen P; Mulari O; Hovinen J
    Bioconjug Chem; 2002; 13(4):870-5. PubMed ID: 12121143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization, and application of Eu(III), Tb(III), Sm(III), and Dy(III) lanthanide chelate nanoparticle labels.
    Huhtinen P; Kivelä M; Kuronen O; Hagren V; Takalo H; Tenhu H; Lövgren T; Härmä H
    Anal Chem; 2005 Apr; 77(8):2643-8. PubMed ID: 15828805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence quenching-based assays for hydrolyzing enzymes. Application of time-resolved fluorometry in assays for caspase, helicase, and phosphatase.
    Karvinen J; Laitala V; Mäkinen ML; Mulari O; Tamminen J; Hermonen J; Hurskainen P; Hemmilä I
    Anal Chem; 2004 Mar; 76(5):1429-36. PubMed ID: 14987100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Micro Arrayed Compound Screening (microARCS) to identify inhibitors of caspase-3.
    Gopalakrishnan SM; Karvinen J; Kofron JL; Burns DJ; Warrior U
    J Biomol Screen; 2002 Aug; 7(4):317-23. PubMed ID: 12230885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificities of caspase family proteases.
    Talanian RV; Quinlan C; Trautz S; Hackett MC; Mankovich JA; Banach D; Ghayur T; Brady KD; Wong WW
    J Biol Chem; 1997 Apr; 272(15):9677-82. PubMed ID: 9092497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homogeneous caspase-3 activity assay using HTRF technology.
    Préaudat M; Ouled-Diaf J; Alpha-Bazin B; Mathis G; Mitsugi T; Aono Y; Takahashi K; Takemoto H
    J Biomol Screen; 2002 Jun; 7(3):267-74. PubMed ID: 12097189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous time-resolved fluorescence quenching assay (TruPoint) for nucleic acid detection.
    Ylikoski A; Elomaa A; Ollikka P; Hakala H; Mukkala VM; Hovinen J; Hemmilä I
    Clin Chem; 2004 Oct; 50(10):1943-7. PubMed ID: 15484334
    [No Abstract]   [Full Text] [Related]  

  • 10. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8.
    Stennicke HR; Renatus M; Meldal M; Salvesen GS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):563-8. PubMed ID: 10947972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-quenching-based homogeneous caspase-3 activity assay using photon upconversion.
    Vuojola J; Riuttamäki T; Kulta E; Arppe R; Soukka T
    Anal Chim Acta; 2012 May; 725():67-73. PubMed ID: 22502613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive characterization of the caspase gene family in insects from the order Lepidoptera.
    Courtiade J; Pauchet Y; Vogel H; Heckel DG
    BMC Genomics; 2011 Jul; 12():357. PubMed ID: 21740565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of oligonucleotides labeled with luminescent lanthanide(III) chelates.
    Jaakkola L; Peuralahti J; Hakala H; Kunttu J; Tallqvist P; Mukkala VM; Ylikoski A; Hovinen J
    Bioconjug Chem; 2005; 16(3):700-9. PubMed ID: 15898740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and application of a fluorogenic assay for monitoring inflammatory caspase activity.
    Ranganathan R; Lenti G; Tassone NM; Scannell BJ; Southern CA; Karver CE
    Anal Biochem; 2018 Feb; 543():1-7. PubMed ID: 29198574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.
    Izban KF; Wrone-Smith T; Hsi ED; Schnitzer B; Quevedo ME; Alkan S
    Am J Pathol; 1999 May; 154(5):1439-47. PubMed ID: 10329597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual-step fluorescence resonance energy transfer-based quenching assay for screening of caspase-3 inhibitors.
    Valanne A; Malmi P; Appelblom H; Niemelä P; Soukka T
    Anal Biochem; 2008 Apr; 375(1):71-81. PubMed ID: 18211811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring apoptosis: caspase inhibitors and activity assays.
    McStay GP; Green DR
    Cold Spring Harb Protoc; 2014 Aug; 2014(8):799-806. PubMed ID: 25086023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and luminescence properties of new red-shifted absorption lanthanide(III) chelates suitable for peptide and protein labelling.
    Maindron N; Poupart S; Hamon M; Langlois JB; Plé N; Jean L; Romieu A; Renard PY
    Org Biomol Chem; 2011 Apr; 9(7):2357-70. PubMed ID: 21321764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minisequencing with acyclonucleoside triphosphates tethered to lanthanide(III) chelates.
    Ollikka P; Ylikoski A; Kaatrasalo A; Harvala H; Hakala H; Hovinen J
    Bioconjug Chem; 2008 Jun; 19(6):1269-73. PubMed ID: 18505280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
    Belizário JE; Lorite MJ; Tisdale MJ
    Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.